Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131754) titled 'A prospective study evaluating the safety and efficacy of yttrium [90Y] carbon microspheres radioembolization in patients with previously treated hepatocellular carcinoma' on Sept. 6.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
Liver cancer
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-27
Target Sample Size: Experimental group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319823
Published by HT Digital Content Services...